The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.

Yang Y, Shangguan Y, Wang X, Liu R, Shen Z, Tang M, Jiang G

Open source

DOI
10.3389/fneur.2023.1307296
Published
2023
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2023.1307296,
  title = {The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.},
  author = {Yang Y and Shangguan Y and Wang X and Liu R and Shen Z and Tang M and Jiang G},
  year = {2023},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2023.1307296},
  url = {https://doi.org/10.3389/fneur.2023.1307296}
}

RIS

TY  - JOUR
TI  - The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.
AU  - Yang Y
AU  - Shangguan Y
AU  - Wang X
AU  - Liu R
AU  - Shen Z
AU  - Tang M
AU  - Jiang G
PY  - 2023
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2023.1307296
UR  - https://doi.org/10.3389/fneur.2023.1307296
ER  - 

APA

Y, Y., Y, S., X, W., R, L., Z, S., M, T., & G, J. (2023). The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.. Frontiers in neurology. https://doi.org/10.3389/fneur.2023.1307296

Source records